Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking approach to diabetes management. These innovative drugs function by mimicking the physiological actions of GLP-1, a hormone released by the https://bookmarksusa.com/story20837075/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes